(5Z)-5-{[5-(4-Fluoro-2-hydroxyphenyl)furan-2-yl]methylidene}-1,3-thiazolidine-2,4-dione
| Title | Journal |
|---|---|
| Pharmacological profile of phosphatidylinositol 3-kinases and related phosphatidylinositols mediating endothelin(A) receptor-operated native TRPC channels in rabbit coronary artery myocytes. | British journal of pharmacology 20120801 |
| A selective inhibitor reveals PI3Kγ dependence of T(H)17 cell differentiation. | Nature chemical biology 20120429 |
| Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors. | Cancer research 20120201 |
| Phosphoinositide-3-kinase/akt - dependent signaling is required for maintenance of [Ca(2+)](i), I(Ca), and Ca(2+) transients in HL-1 cardiomyocytes. | Journal of biomedical science 20120101 |
| A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance. | Molecular cancer research : MCR 20110701 |
| Key role of phosphoinositide 3-kinase class IB in pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20101015 |
| Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma. | Journal of medicinal chemistry 20060629 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |